TP53 and atrial fibrillation: In A549 cells, AF monotherapy even significantly reduced the amount of cellular ROS (Figure 3A), indicating that in the presence of low levels of WT p53 protein, other antioxidant systems beside the Trx/TrxR system counteract AF-induced oxidative stress.